Leptin regulation of proangiogenic molecules in benign and cancerous endometrial cells

International Journal of Cancer

Volumn 123, Issue 12, 2008, Pages 2782-2790

  Carino, Cecilia ^a   Olawaiye, Alexander B ^b,c   Cherfils, Salandre ^d   Serikawa, Takehiro ^b,c   Lynch, Maureen P ^b,c   Rueda, Bo R ^b,c   Gonzalez, Ruben R ^a,b,d  

^a BOSTON BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

Endometrial cancer; Endometrial epithelial cells; IL 1R; IL1; Leptin; Leptin signaling pathways; LIF; LIFR; Proangiogenesis molecules; VEGF; VEGFR2

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; JANUS KINASE 2; LEPTIN; LEUKEMIA INHIBITORY FACTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PHOSPHATIDYLINOSITOL 3 KINASE; RAPAMYCIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; WORTMANNIN;

ARTICLE; BENIGN TUMOR; CANCER CELL CULTURE; ENDOMETRIUM CANCER; ENDOMETRIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; BLOTTING, WESTERN; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; INTERLEUKIN-1BETA; LEPTIN; LEUKEMIA INHIBITORY FACTOR; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN KINASES; RECEPTORS, INTERLEUKIN-1; RECEPTORS, OSM-LIF; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 57349175662     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23887     Document Type: Article

References (70)

1. Matarese G, Alviggi C, Sanna V, Howard JK, Lord GM, Carravetta C, Fontana S, Lechler RI, Bloom SR, De Placido G. Increased leptin levels in serum and peritoneal fluid of patients with pelvic endometriosis. J Clin Endocrinol Metab 2000;85:2483-7.
2. Wu MH, Chuang PC, Chen HM, Lin CC, Tsai SJ. Increased leptin expression in endometriosis cells is associated with endometrial stromal cell proliferation and leptin gene up-regulation. Mol Hum Reprod 2002;8:456-64.
3. Petridou E, Belechri M, Dessypris N, Koukoulomatis P, Diakomanolis E, Spanos E, Trichopoulos D. Leptin and body mass index in relation to endometrial cancer risk. Ann Nutr Metab 2002;46:147-51.
4. La Cava A, Matarese G. The weight of leptin in immunity. Nat Rev Immunol 2004;4:371-9.
5. Giudice LC, Kao LC. Endometriosis. Lancet (Seminar) 2004;364:1789-99.
6. Gonzalez RR, Chefils S, Escobar M, Yoo JH, Carino C, Styer AK, Sullivan BT, Sakamoto H, Olawaiye A, Serikawa T, Lynch MP, Rueda BR. Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (VEGF) and its receptor type two (VEGF-R2). J Biol Chem 2006;281:26320-8.
7. Koda M, Sulkowska M, Wincewicz A, Kanczuga-Koda L, Musiatowicz B, Szymanska M, Sulkowski S. Expression of leptin, leptin receptor, and hypoxia-inducible factor 1 alpha in human endometrial cancer. Ann N Y Acad Sci 2007;1095:90-8.
8. Styer A, Gonzalez RR, Leavis P, Petrozza J, Rueda BR. In vivo disruption of leptin receptor function impairs the establishment and viability of endometriosis-like lesions. Fertil Steril 2005;84:S389-S90.
9. Styer AA, Sullivan BT, Puder M, Arsenault D, Petrozza JC, Serikawa T, Chang S, Hasan T, Gonzalez RR, Rueda BR. Ablation of leptin signaling disrupts the establishment, development of and maintenance of endometriosis-like lesions in a murine model. Endocrinology 2007;149:506-14.
10. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995;1:1155-61.
11. Tartaglia LA. The leptin receptor. J Biol Chem 1997;272:6093-6.
12. Baumann H, Morella KK, White DW, Dembski M, Bailon PS, Kim H, La CF, Tartaglia LA. The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. Proc Natl Acad Sci USA 1996;93:8374-8.
13. Gonzalez RR, Caballero-Campo P, Jasper M, Mercader A, Devoto L, Simon C. Leptin and leptin receptor are expressed in the human endometrium and endometrial leptin secretion is regulated by the human blastocyst. J Clin Endocrinol Metab 2000;85:4883-8.
14. Gonzalez RR, Simon C, Caballero-Campo P, Norman R, Chardonnens D, Devoto L, Bischof P. Leptin and reproduction. Hum Reprod Update 2000;6:290-300.
15. Kitawaki J, Koshiba H, Ishihara H, Kusuki I, Tsukamoto K, Honjo H. Expression of leptin receptor in human endometrium and fluctuation during the menstrual cycle. J Clin Endocrinol Metab 2000;85:1946-50.
16. Yuan SS, Tsai KB, Chung YF, Chan TF, Yeh YT, Tsai LY, Su JH. Aberrant expression and possible involvement of the leptin receptor in endometrial cancer. Gynecol Oncol 2004;92:769-75.
17. Hekerman P, Zeidler J, Bamberg-Lemper S, Knobelspies H, Lavens D, Tavernier J, Joost HG, Becker W. Pleiotropy of leptin receptor signalling is defined by distinct roles of the intracellular tyrosines. FEBS J 2005;272:109-19.
18. Ghilardi N, Ziegler S, Wiestner A, Stoffel R, Heim MH, Skoda RC. Defective STAT signaling by the leptin receptor in diabetic mice. Proc Natl Acad Sci USA 1996;93:6231-5.
19. Wang Y, Kuropatwinski KK, White DW, Hawley TS, Hawley RG, Tartaglia LA, Baumann H. The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. J Biol Chem 1997;272:16216-23.
20. Takahashi Y, Okimura Y, Mizuno I, Iida K, Takahashi T, Kaji H, Abe H, Chihara K. Leptin induces mitogen-activated protein kinase- dependent proliferation of C3H10T1/2 cells. J Biol Chem 1997;272:12897-900.
21. Sweeney G. Leptin signalling. Cell Signal 2002;14:655-63.
22. Onuma M, Bub JD, Rummel TL, Iwamoto Y. Prostate cancer cell-adipocyte interaction: leptin mediates androgen-independent prostate cancer cell proliferation through c-Jun NH2-terminal kinase. J Biol Chem 2003;278:42660-7.
23. Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Müller C, Carling D, Kahn BB. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 2002;415:339-43.
24. Alfer J, Muller-Schottle F, Classen-Linke I, von Rango U, Happel L, Beier-Hellwig K, Rath W, Beier HM. The endometrium as a novel target for leptin: differences in fertility and subfertility. Mol Hum Reprod 2000;6:595-601.
25. Gonzalez RR, Rueda BR, Ramos MP, Littell RD, Glasser S, Leavis PC. Leptin-induced increase in leukemia inhibitory factor and its receptor by human endometrium is partially mediated by interleukin 1 receptor signaling. Endocrinology 2004;145:3850-7.
26. Ramos MP, Rueda BR, Leavis PC, Gonzalez RR. Leptin serves as an upstream activator of an obligatory signaling cascade in the embryo-implantation process. Endocrinology 2005;146:694-701.
27. Tanaka T, Utsunomiya T, Bai T, Nakajima S, Umesaki N. Leptin inhibits decidualization and enhances cell viability of normal human endometrial stromal cells. Int J Mol Med 2003;12:95-8.
28. Somasundar P, McFadden DW, Hileman SM, Vona-Davis L. Leptin is a growth factor in cancer. J Surg Res 2004;116:337-9.
29. Garofalo C, Surmacz E. Leptin and cancer. J Cell Physiol 2006;207:212-22.
30. Gonzalez RR, Leavis P. Leptin upregulates b3-integrin expression and interleukin-1b upregulates leptin and leptin receptor expression in human endometrial epithelial cell cultures. Endocrine 2001;16:21-8.
31. Gonzalez RR, Leary K, Petrozza JC, Leavis PC. Leptin regulation of the interleukin-1 system in human endometrial cells. Mol Hum Reprod 2003;9:151-8.
32. Fukuda J, Kae N, Bing S, Sujie S, Yasushi K, Isao M. Effects of leptin on the production of cytokines by cultured human endometrial stromal and epithelial cells. Fertil Steril 2003;80:783-7.
33. Sharma D, Saxena NK, Vertino PM, Anania FA. Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathways. Endocr Relat Cancer 2006;13:629-40.
34. Bogusiewicz M, Semczuk A, Gogacz M, Skomra D, Jakowicki JA, Rechberger T. Lack of correlation between leptin receptor expression and PI3-K/Akt signaling pathway proteins immunostaining in endometrioid-type endometrial carcinomas. Cancer Lett 2006;238:61-68.
35. Gonzalez RR, Palomino A, Boric A, Vega M, Devoto L. A quantitative evaluation of alpha1, alpha4, alphaV and beta3 endometrial integrins of fertile and unexplained infertile women during the menstrual cycle. A flow cytometric appraisal. Hum Reprod 1999;14:2485-92.
36. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
37. Hubschle T, Thom E, Watson A, Roth J, Klaus S, Meyerhof W. Leptin-induced nuclear translocation of stat3 immunoreactivity in hypothalamic nuclei involved in body weight regulation. J Neurosci 2001;21:2413-24.
38. Ihle JN. Cytokine receptor signaling. Nature 1995;377:591-4.
39. Darnel JE. STATs and gene regulation. Science 1997;277:1630-5.
40. Bjorbaek C, Buchholz RM, Davis SM, Bates SH, Pierroz DD, Gu H, Neel BG, Myers MG, Jr, Flier JS. Divergent roles of SHP-2 in ERK activation by leptin receptors. J Biol Chem 2001;276:4747-55.
41. Kloek C, Haq AK, Dunn SL, Lavery HJ, Bank AS, Myers MG Jr. Regulation of Jak kinases by intracellular leptin receptor sequences. J Biol Chem 2002;277:41547-55.
42. Murakami T, Yamashita T, Iida M, Kuwajima M, Shima K. A short form of leptin receptor performs signal transduction. Biochem Biophys Res Commun 1997;231:26-9.
43. Kellerer M, Koch M, Metzinger E, Mushack J, Capp E, Haring HU. Diabetologia 1997;40:1358-62.
44. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997;18:4-25.
45. Giraudo E, Primo L, Audero E, Gerber HP, Koolwijk P, Soker S, Klagsbrun M, Ferrara N, Bussolino F. Tumor necrosis factor-α regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells. J Biol Chem 1998;273:22128-35.
46. Bouloumie A, Hannes C, Drexler A, Lafontan M, Busse R. Leptin, the product of Ob gene, promotes angiogenesis. Circ Res 1998;83:1059-66.
47. Park HY, Kwon HM, Lim HJ, Hong BK, Lee JY, Park BE. Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Exp Mol Med 2001;33:95-102.
48. Okumura M, Yamamoto M, Sakuma H, Kojima T, Maruyama T, Jamali M, Cooper DR, Yasuda K. Leptin and high glucose stimulate cell proliferation in MCF-7 human breast cancer cells: reciprocal involvement of PKC-alpha and PPAR expression. Biochim Biophys Acta 2002;1592:107-16.
49. Islami D, Bischof P, Chardonnens D. Modulation of placental vascular endothelial growth factor by leptin and hCG. Mol Hum Reprod 2003;9:395-8.
50. Gonzalez RR, Leavis PC. A peptide derived from the human leptin molecule is a potent inhibitor of the leptin receptor function in rabbit endometrial cells. Endocrine 2003;21:185-95.
51. Salven P, Hattori K, Heissig B, Rafi S. Interleukin-1 promotes angiogenesis in vivo via VEGFR-2 pathway by inducing inflammatory cell VEGF synthesis and secretion. FASEB J 2002;16:1471-3.
52. Coxon A, Bolon B, Estrada J, Kaufman S, Scully S, Rattan A, Duryea D, Hu YL, Rex K, Pacheco E, Van G, Zack D, et al. Inhibition of interleukin-1 but not tumor necrosis factor suppresses neovascularization in rat models of corneal angiogenesis and adjuvant arthritis. Arthritis Rheum 2002;46:2604-12.
53. Gera JF, Mellinghoff IK, Shi Y, Rettig MB, Tran C, Hsu JH, Sawyers CL, Lichtenstein LK. AKT activity determines sensitivity to mammalian target of rapamycin (mTOR) inhibitors by regulating cyclin D1 and c-myc expression. J Biol Chem 2004;279:2737-46.
54. Fruhbeck G. Intracellular signalling pathways activated by leptin. Biochem J 2006;393:7-20.
55. Wlodarski P, Kasprzycka M, Liu X, Marzec M, Robertson ES, Slupianek A, Wasik MA. A possible linkage between AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway. Cancer Res 2005;65:7800-8.
56. Leseux L, Hamdi SM, al Saati T, Capilla F, Recher C, Laurent G, Bezombes C. Syk-dependent mTOR activation in follicular lymphoma cells. Blood 2006;108:4156-62.
57. Ma L, Chen Z, Erdjument-Bromage H, Tempst P, Pandolfi PP. Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell 2005;121:179-93.
58. Starr R, Novak U, Willson TA, Inglese M, Murphy V, Alexander WS, Metcalf D, Nicola NA, Hilton DJ, Ernstet E. Distinct roles for leukemia inhibitory factor receptor alpha-chain and gp130 in cell type-specific signal transduction. J Biol Chem 1997;272:19982-6.
59. Yu C, Kastin AJ, Tu H, Pan W. Opposing effects of proteasomes and lysosomes on LIFR: modulation by TNF. J Mol Neurosci 2007;32:80-9.
60. Kimber SJ. Leukaemia inhibitory factor in implantation and uterine biology. Reproduction 2005;130:131-45.
61. Mylonas I, Makovitzky J, Shabani N, Richter DU, Kuhn C, Jeschke U, Briese V, Friese K. Leukaemia inhibitory factor (LIF) is immunohistochemically expressed in normal, hyperplastic and malignant endometrial tissue. Eur J Obstet Gynecol Reprod Biol 2005;118:101-8.
62. Paradis H, Gendron RL. LIF transduces contradictory signals on capillary outgrowth through induction of stat3 and (P41/43) MAP kinase. J Cell Sci 2000;113:4331-9.
63. Ferrara N, Winer J, Henzel WJ. Pituitary follicular cells secrete an inhibitor of aortic endothelial cell growth: identification as leukemia inhibitory factor. Proc Natl Acad Sci USA 1992;89:698-702.
64. Vasse M, Pourtau J, Trochon V, Muraine M, Vannier JP, Lu H, Soria J, Soria C. Oncostatin M induces angiogenesis in vitro and in vivo arteriosclerosis thrombosis, and vascular. Biology 1999;19:1835-42.
65. Modugno F, Ness RB, Chen C, Weiss NS. Inflammation and endometrial cancer: a hypothesis. Cancer Epidemiol Biomarkers Prev 2005;14:2840-7.
66. Berry KK, Varney ML, Dave BJ, Bucana CD, Fidler IJ, Singh RK. Expression of interleukin-8 in human metastatic endometrial carcinoma cells and its regulation by inflammatory cytokines. Int J Gynecol Cancer 2001;11:54-60.
67. Van Le L, Haskill S, Jaffe GJ, Fowler WG, Jr. Expression of interleukin-1 and interleukin-1 receptor antagonists in endometrial cancer. Gynecol Oncol 1991;42:161-4.
68. Sims JE, Gayle MA, Slack JL, Alderson MR, Bird TA, Giri JG, Colotta F, Re F, Mantovani A, Shanebeck K, Grabstein KH, Dower SK. Interleukin 1 signaling occurs exclusively via the type I receptor. Proc Natl Acad Sci USA 1993;90:6155-9.
69. Ktori C, Shepherd PR, O'Rourke LTN. F-alpha and leptin activate the alpha-isoform of class II phosphoinositide 3-kinase. Biochem Biophys Res Commun 2003;306:139-43.
70. Yasukawa H, Sasaki A, Yoshimura A. Negative regulation of cytokine signaling pathways. Ann Rev Immunol 2000;18:143-6.